Current situation and progress in integrative medicine in China

Ai-ping Lu; Xiao-rong Ding; Ke-ji Chen

doi:10.1007/s11655-008-240-z

Your Location：

Home >

Browse articles >

Current situation and progress in integrative medicine in China

Updated：2021-08-27

- Current situation and progress in integrative medicine in China
- Chinese Journal of Integrative Medicine Vol. 14, Issue 3, Pages: 234-240(2008)
- Affiliations：
  
  Chinese Association of Integrative Medicine, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-008-240-z
  CLC：
- Published：2008，
  
  Published Online：14 October 2008，
Scan for full text
Lu, Ap., Ding, Xr. & Chen, Kj. Current situation and progress in integrative medicine in China., Chin. J. Integr. Med. 14, 234–240 (2008). https://doi.org/10.1007/s11655-008-240-z

Ai-ping Lu, Xiao-rong Ding, Ke-ji Chen. Current situation and progress in integrative medicine in China. [J]. Chinese Journal of Integrative Medicine 14(3):234-240(2008)
Lu, Ap., Ding, Xr. & Chen, Kj. Current situation and progress in integrative medicine in China., Chin. J. Integr. Med. 14, 234–240 (2008). https://doi.org/10.1007/s11655-008-240-z DOI：

Ai-ping Lu, Xiao-rong Ding, Ke-ji Chen. Current situation and progress in integrative medicine in China. [J]. Chinese Journal of Integrative Medicine 14(3):234-240(2008) DOI： 10.1007/s11655-008-240-z.

摘要

In the past 50 years

integration of traditional Chinese medicine and Western medicine

known as the Chinese version of integrative medicine (IM)

has achieved significant developments. In this article

the present situation and progress in IM development in China are summarized from the aspects of IM application

policy making

scientific research

education

academic exchanges

and its future development. With continuous support from the Chinese government and successful scientific achievements in the past 50 years

the authors believe that IM will be moving forwards to a full globalization.

Abstract

In the past 50 years

integration of traditional Chinese medicine and Western medicine

known as the Chinese version of integrative medicine (IM)

has achieved significant developments. In this article

the present situation and progress in IM development in China are summarized from the aspects of IM application

policy making

scientific research

education

academic exchanges

and its future development. With continuous support from the Chinese government and successful scientific achievements in the past 50 years

the authors believe that IM will be moving forwards to a full globalization.

关键词

current situation and progressIntegrative MedicineChina

Keywords

current situation and progressIntegrative MedicineChina

references

Wang ZR, Li JW, Chen KJ. Reviewing over the history of integrative medicine in China in 20th century. Chin J Integr Tradit West Med (Chin) 2005;25(11):1033–1037.

Chen KJ, Lu AP. Situation of integrative medicine in China: results from a national survey in 2004. Chin J Integr Med 2006;12(3):161–165.

Lu AP, Chen KJ. Pondering on syndrome differentiation of diseases. Chin J Integr Tradit West Med (Chin) 2005;25(9):843–845.

He YT, Zha QL, Yan XP, et al. Analysis on symptomatic factors of rheumatoid arthritis and its correlation with therapeutic efficacy. Chin J Integr Tradit West Med (Chin) 2005;25(12):1077–1081.

Liu BY, Hu JQ, Xie YM, et al. Effects of integrative Chinese and Western medicine on arterial oxygen saturation in patients with severe acute respiratory syndrome. Chin J Integr Tradit West Med (Chin) 2004;10(2):117–122.

Chen KJ, Xu H, Shi DZ, et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chin Med J 2006;119(1):6–13.

Xu H, Chen KJ, Shi DZ, et al. Clinical study of Xiongshao Capsule in preventing restenosis after coronary interventional treatment. Chin J Integr Med 2002;8(3):162–166.

Gao Y. Some key problems in study on clinical evaluation criterion for the combination of disease and syndrome of stroke. Chin J Integr Tradit West Med (Chin) 2007;27(9):778–779.

Gu WL, Shi ZX. The effective evaluation of TCM from viewpoint of cardiovascular disease. J Tradit Chin Med 2006;47(6):415–416.

Tang QS. Progress and commentary on research of integrated Chinese and Western medicine on poststroke depression. Chin J Integr Tradit West Med (Chin) 2007;27(9):776–777.

Liu QY, Song J, Chen KJ. Progress of studies on treatment of ischemic apoplexy by Chinese herbal medicine. Chin J Integr Tradit West Med (Chin) 2000;20(4):309–311.

Wu XZ. Modern research on purgation method of traditional Chinese medicine—application of the method in acute abdominal diseases and experimental studies. Chin J Integr Med 1998;4(1):5–8.

Shang TY. Treatment of fractures and joint injury by integrated traditional Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 1988;8(Suppl 2):51–52.

Han JS. From acupuncture analgesia to heroin detoxification. Chin J Integr Med 1997;3(4):311–316.

Li TQ, Mao B, Wang G, et al. Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine. Chin J Integr Med 2008;14(1):6–9.

Lin L, Han Y, Yang ZM, et al. Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2003;23(6):409–413.

Guan FL. The summary of acute pancreatitis treated with Chinese and Western medinice. The 9th National Academic Conference of Integrative Medicine on General Surgery, 2005:66–70

The Coorperation Group of Phase I Clinical Trial of Compound Huangdai Tablet. Phase I clinical trial of compound Huangdai Tablet in newly diagnosed acute promyelocytic leukemia. Chin J Hemat (Chin) 2006;27(12):801–804.

Pan YL, Pan YZ. Observation on effects of Zhiling Capsule (志苓胶囊) in treating 400 patients with various types of cancer in mid-advanced stage. Chin J Integr Tradit West Med (Chin) 2007;27(9):807–809.

Zhou DH, Lin LZ, Zhou YQ, et al. Analysis of short-term therapeutic efficacy of integrated traditional and Western medicine in treating non-small cell lung cancer. Chin J Integr Tradit West Med (Chin) 2005;25(12):1061–1065.

Chen XM, Chen J, Chen YP, et al. Multicentered, randomized, controlled clinical trial on patients with IgA nephropathy of qi-yin deficiency syndrome type. Chin J Integr Tradit West Med (Chin) 2007;27(2):101–105.

Lei Y, Lu QS, Ma XC, et al. Clinical study on effect of Qingxin Capsule (清心胶囊) in treating patients with hypertension of mild or moderate degree. Chin J Integr Tradit West Med (Chin) 2005;25(2):114–118.

Lu AP. Making repeated clinical trials aiming at finding specific indications is the way for improving clinical efficacy of traditional Chinese medicine. Chin J Integr Tradit West Med (Chin) 2006;26(7):588–589.

He YT, Lu AP, Lu C, et al. Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis. Am J Chin Med 2008;36:1–9.

He YT, Lu AP, Zha YL, et al. Differential effect on symptoms treated with traditional Chinese medicine and Western combination therapy in RA patients. Complement Ther Med 2008;16:206–211.

Lei Y, Chen KJ, Liu JG, et al. Effect of Xuefu Zhuyu Pill (血府逐瘀丸) on platelet activating factor expression in patients with unstable angina pectoris. Chin J Integr Med 2002;8(4):267–270.

Shen ZY. The location of deficiency syndrome of kidney Yang. Chin Med J 1999;112(11):973–975.

Duan YL, Zhang XM, Shen ZY, et al. Effect of three composite recipes on content of monoamine transmitters in hypothalamus induced by intracerebroventricular injection of interleukin-1 in rats. Chin J Integr Tradit West Med (Chin) 1999;19(3):164–166.

Shen ZY, Chen Y, Huang JH, et al. Syndrome differentiation through drug effects in mapping the two regulatory pathways of gene networks in Shen deficiency syndrome. Chin J Integr Tradit West Med (Chin) 2006;26(6):521–525.

Lu AP. Influence of TCM syndrome theory on thoughts of diseases treatment. Chin J Integr Tradit West Med (Chin) 2001;21(4):309–311.

He YT, Lu AP, Zha QL, et al. Correlations between symptoms as assessed in traditional Chinese medicine (TCM) and ACR20 efficacy response. A comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine. J Clin Rheumatol 2007;13:317–321.

Li Y, Li S, Lu AP. Comparative analysis via data mining on the clinical features of Western medicine and Chinese medicine in diagnosing rheumatoid arthritis. Chin J Integr Tradit West Med (Chin) 2006;26(11):988–991.

Li S, Lu AP, Zhang L, et al. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions. World J Gastroenterol 2003;9:755–758.

Shen LS, Cai YX, Liu CJ, et al. Recent advances in TCM tongue manifestation information acquisition and analysis. World Sci Technol-Modern Tradit Chin Med 2007;9(5):97–101.

Jiang B, Song ZC, Yu P. The development overview of pulse transducer. Sci Technol Inform (Chin) 2007;5:22.

Zhu QW, Niu X, Yang J, et al. Methodology approach of pulse diagnosis research based on complexity science theory. China J Tradit Chin Med Pharm 2007;22(5):265–268.

Tan B, Song JP, Thou Tharith, et al. Radomized controlled trial of two kinds of compound dihydroartemisinin with or without trimethoprim for uncomplicated falciparum malaria. J Gungzhou Univ Tradit Chin Med (Chin) 2007;24(2):100–103.

Yue L, Zhu DN, Yan YQ, et al. Relationship between components changes and efficacy of Shengmaisan VII. Chemical dynamic change of schisandrin in Shengmaisan. China J Chin Materia Medica (Chin) 2006;31(12):1010–1012.

Zhang ZJ, Li P, Wang Z, et al. A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Res 2006;1123:188–195.

Wang L, Zhou GB, Chen Z, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 2008;105:4826–4831.

Cheng Y, Chen M, Tong W. An approach to comparative analysis of chromatographic fingerprints for assuring the quality of botanical drugs. J Chem Inf Comput Sci 2003;43:1068–1076.

Zhang WD, Lu C, Zhao HY, et al. Effect of combination glycyrrhizin and triptolide on TNF-α and IL-10 in serum of collagen induced arthritis rats. China J Chin Materia Medica (Chin) 2007;32(5):414–417.

Xiao C, Lu C, Lu AP, et al. The effects of triptolide on enteric mucosal immune responses of DBA/1 mice with collagen induced arthritis. Planta Med 2006;72:1268–1272.

Zhang QZ, Wu XJ, Li D, et al. Comparison of DNA fingerprinting and active compound content among different species of Radix Astragali. China J Chin Materia Medica (Chin) 2005;40(6):457–459.

Liu ZL, Li LF, Song ZQ, et al. New chemical constituents from Radix Polygoni Multiflori after processing. J Chin Med Materials (Chin) 2007;30(12):1505–1507.

Lu AP, Li CS. The pathologic mechanism research on kidney deficiency arthralgia zheng. J Tradit Chin Med (Chin) 1995;36(8):492–493.

FULL TEXT LINK

More>

Views

358

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Situation of integrative medicine in China: Results from a national survey in 2004

Chinese medicine education and its challenges in the United States

Search of novel model for integrative medicine

Syndrome pattern and its application in parallel randomized controlled trials

The Western model of integrative oncology — the contribution of Chinese medicine

Related Author

No data

Related Institution

Chinese Association of Integrative Medicine

Acupuncture & Oriental Medicine Program, National University of Health Sciences, Lombard

Interdisciplinary School of Health Sciences, University of Pune, Pune

Former Director, WHO Liaison Office New York

Division of Clinical Medicine, School of Korean Medicine, Pusan National University, Yangsan, Republic of Korea

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰